Biotechnology Fund Class Fund Investor Sentiment

RYBOX Fund  USD 58.00  0.38  0.65%   
Slightly above 62% of Biotechnology Fund's investor base is looking to short. The analysis of overall sentiment of trading Biotechnology Fund Class mutual fund suggests that many investors are alarmed at this time. Biotechnology Fund's investing sentiment can be driven by a variety of factors including economic data, Biotechnology Fund's earnings reports, geopolitical events, and overall market trends.
  
over a year ago at news.google.com         
CA Rapid Response fund not rapid for flood victims - CalMatters
Google News at Macroaxis
a day ago at finance.yahoo.com         
Nektar Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset T...
Yahoo News
few days ago at thefly.com         
Nektar management to meet virtually with BTIG NKTR
news
over a week ago at newswire.com         
Donald Stuart Seigal Aka ANTHEMan Releases 3 Brand New Super Catchy Love Songs Youtubes Just for You
news
over a week ago at thelincolnianonline.com         
Peapod Lane Capital LLC Makes New 1.03 Million Investment in Nektar Therapeutics
news
over two weeks ago at simplywall.st         
Lacklustre Performance Is Driving Nektar Therapeutics 34 percent Price Drop
Simply Wall St News at Macroaxis
over two weeks ago at finance.yahoo.com         
Down -38.51 percent in 4 Weeks, Heres Why Nektar Looks Ripe for a Turnaround
Yahoo News
over three weeks ago at finance.yahoo.com         
Nektar Could Find a Support Soon, Heres Why You Should Buy the Stock Now
Yahoo News
over a month ago at news.google.com         
JPMorgan Chase Co. Buys 606,057 Shares of Nektar Therapeutics - MarketBeat
Google News at Macroaxis
over a month ago at finance.yahoo.com         
Arvinas Updates Guidance for First- and Second-Line Phase 3 Combination Trials with Vepdegestrant, H...
Yahoo News
over a month ago at insidermonkey.com         
Why Nektar Therapeutics Is Among the Best Penny Stocks to Invest In According to Media?
insidermonkey News
a day ago at gurufocus.com         
IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence
Gurufocus Stories at Macroaxis
few days ago at thelincolnianonline.com         
JPMorgan Chase Co. Cuts IQVIA Price Target to 232.00
news
few days ago at thelincolnianonline.com         
Invera Wealth Advisors LLC Grows Stock Position in IQVIA Holdings Inc.
news
few days ago at kalkinemedia.com         
How Is IQVIA Holdings Inc. Expanding Its Role in Life Sciences
news
over a week ago at thelincolnianonline.com         
Montag A Associates Inc. Cuts Stake in IQVIA Holdings Inc.
news
over a week ago at simplywall.st         
Earnings growth of 2.5 percent over 1 year hasnt been enough to translate into positive returns for ...
Simply Wall St News at Macroaxis
over a week ago at thelincolnianonline.com         
SFE Investment Counsel Has 3.46 Million Position in IQVIA Holdings Inc.
news
over a week ago at zacks.com         
SP Global Q4 Earnings Revenues Surpass Estimates, Increase YY
zacks News
over two weeks ago at finance.yahoo.com         
IQVIA Holdings Inc. Just Released Its Full-Year Earnings Heres What Analysts Think
Yahoo News
over two weeks ago at gurufocus.com         
Q4 2024 IQVIA Holdings Inc Earnings Call Transcript
Gurufocus Stories at Macroaxis
over a year ago at www.macroaxis.com         
Disposition of 110447 shares by Thomas Watkins of Horizon Pharma subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Institutional owners may consider drastic measures as Vir Biotechnology, Inc.s recent US85m drop add...
Google News at Macroaxis
over a year ago at businesswire.com         
Horizon Therapeutics plc Rule 2.12 Announcement
businesswire News
over a year ago at benzinga.com         
Heres How Much 1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth Today
benzinga news
over a year ago at news.google.com         
U.S. FTC allows Amgen to move forward with 27.8 bln Horizon deal - CNBC - Marketscreener.com
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Toronto Dominion Bank Buys 185,145 Shares of Horizon Therapeutics Public Limited
news
over a year ago at finance.yahoo.com         
Horizon Up as FTC Pauses Acquisition by Amgen Lawsuit
Yahoo News
over a year ago at finance.yahoo.com         
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocac...
Yahoo News
over a year ago at marketwatch.com         
George Soros has a big stake in this stock but its posted a roughly 9 percent loss this year. Are th...
marketwatch News
over a year ago at thelincolnianonline.com         
Horizon Therapeutics Public Issues Earnings Results
news
a day ago at arstechnica.com         
Claude 3.7 Sonnet debuts with extended thinking to tackle complex problems
news
3 days ago at gurufocus.com         
Insider Sell Ourania Tatsis Sells Shares of Vertex Pharmaceuticals Inc
Gurufocus Stories at Macroaxis
few days ago at thelincolnianonline.com         
Mattern Capital Management LLC Grows Stock Holdings in Vertex Pharmaceuticals Incorporated
news
few days ago at thelincolnianonline.com         
Disposition of 1111 shares by Altshuler David of Vertex Pharmaceuticals at 480.0 subject to Rule 16b...
news
few days ago at finance.yahoo.com         
Cloud AI Market to USD 847.8 Billion by 2032 SNS Insider
Yahoo News
few days ago at finance.yahoo.com         
GLP-1RAs and opioid use disorder a new frontier in addiction treatment
Yahoo News
six days ago at simplywall.st         
Vertex Has Announced That It Will Be Increasing Its Dividend To 50.00
Simply Wall St News at Macroaxis
over a week ago at techcrunch.com         
Acquisition by Charles Wagner of 10262 shares of Vertex Pharmaceuticals subject to Rule 16b-3
news
over a week ago at thelincolnianonline.com         
Newman Dignan Sheerar Inc. Sells 36 Shares of Vertex Pharmaceuticals Incorporated
news
over a week ago at thelincolnianonline.com         
Head-To-Head Review Athira Pharma vs. CRISPR Therapeutics
news
over a year ago at reuters.com         
Pfizer forecasts 2024 profit, revenue below Wall Street expectations
reuters
over a year ago at seekingalpha.com         
Pfizer stock slips as 2024 guidance disappoints
seekingalpha News
over a year ago at cnbc.com         
Why investors should only trade a name like Linde on fundamentals
cnbc News
over a year ago at finance.yahoo.com         
Were Interested To See How Seagen Uses Its Cash Hoard To Grow
Yahoo News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at dragonflycap.com         
5 Trade Ideas for MondayArista, Comerica, Interactive Brokers, Seagen and Teck Resources
news
over a year ago at benzinga.com         
100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today
benzinga news
over a year ago at businesswire.com         
TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Fr...
businesswire News
over a year ago at thelincolnianonline.com         
Seagen Inc. Receives 193.00 Average PT from Analysts
news
a minute ago at zacks.com         
Regeneron Q4 Earnings and Revenues Beat Estimates
zacks News
3 days ago at thelincolnianonline.com         
Centricity Wealth Management LLC Makes New Investment in Regeneron Pharmaceuticals, Inc.
news
few days ago at gurufocus.com         
Regeneron Pharmaceuticals Faces Mounting Pressure on Sales, Legal Fronts -- Hagens Berman
Gurufocus Stories at Macroaxis
few days ago at benzinga.com         
Whats Going On With CrowdStrike Shares Friday?
benzinga news
few days ago at gurufocus.com         
REGN INVESTOR ALERT Bronstein, Gewirtz Grossman LLC Announces that Regeneron ...
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Regeneron Pharmaceuticals Faces Mounting Pressure on Sales, Legal Fronts -- Hagens Berman
Gurufocus Stories at Macroaxis
few days ago at finance.yahoo.com         
TEPEZZA Market Sales on the Rise Due to the Strong Growth Driven by Demand for Thyroid Eye Disease T...
Yahoo News
six days ago at globenewswire.com         
Regeneron Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending Contact Levi Korsinsky...
Macroaxis News: globenewswire.com
six days ago at finance.yahoo.com         
Prevent Blindness Kicks Off Second Annual Retinopathy of Prematurity Awareness Week, Feb. 24- March ...
Yahoo News
six days ago at gurufocus.com         
Dupixent sBLA Accepted for FDA Priority Review for
Gurufocus Stories at Macroaxis
a minute ago at accesswire.com         
Class Action Filed Against Moderna, Inc. Seeking Recovery for Investors - Contact Levi Korsinsky
news
2 days ago at seekingalpha.com         
Notable healthcare headlines for the week UnitedHealth, Moderna, Sanofi in focus
seekingalpha News
3 days ago at thelincolnianonline.com         
Moderna, Inc. Shares Sold by CIBC Asset Management Inc
news
few days ago at seekingalpha.com         
Moderna, Novavax rise as new bat coronavirus identified in China
seekingalpha News
few days ago at patch.com         
Summer Camping, Glamping, And Marina Reservation Open For Fire Island
patch News
few days ago at gurufocus.com         
Why Moderna Inc May Struggle to Outperform A Look at Future Challenges
Gurufocus Stories at Macroaxis
few days ago at apnews.com         
Connecticut Sun dont plan on trading Marina Mabrey, who asked to be dealt this month
Macroaxis News: apnews.com
few days ago at insidermonkey.com         
Why Moderna Went Up on Tuesday?
insidermonkey News
six days ago at kalkinemedia.com         
Moderna has limited upside Barclays
news
six days ago at finance.yahoo.com         
Why Moderna Stock Is Up Today
Yahoo News
a day ago at thelincolnianonline.com         
Callan Capital LLC Has 202,000 Stock Holdings in Incyte Co.
news
few days ago at finance.yahoo.com         
Nebulizer Patent Landscape Report 2024 Innovative Developments Fuel Market Growth
Yahoo News
few days ago at finance.yahoo.com         
BESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment
Yahoo News
few days ago at gurufocus.com         
ARMISTICE CAPITAL, LLC Increases Stake in Altamira Therapeutics Ltd
Gurufocus Stories at Macroaxis
six days ago at investors.com         
Incyte Stock Sees Relative Strength Rating Rise To 71
Investors Business Daily at Macroaxis
six days ago at thelincolnianonline.com         
Incyte Co. Short Interest Up 14.9 percent in January
news
over a week ago at gurufocus.com         
ARMISTICE CAPITAL, LLCs Strategic Acquisition of T Stamp Inc Shares
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
Brokerages Set Incyte Co. Price Target at 75.71
news
over a week ago at finance.yahoo.com         
Companion Diagnostics Market Trends 2019-2024 and Forecast to 2034 - Rising Number of Targeted Thera...
Yahoo News
over a week ago at insidermonkey.com         
Incyte Corporation Q4 2024 Earnings Call Transcript
insidermonkey News
a day ago at finance.yahoo.com         
Myriad Genetics Announces Senior Leadership Transition
Yahoo News
3 days ago at thelincolnianonline.com         
Kintegral Advisory LLC Sells 1,582 Shares of Illumina, Inc.
news
few days ago at finance.yahoo.com         
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly sc...
Yahoo News
few days ago at gurufocus.com         
Illumina Inc Unveils Revolutionary Spatial Transcriptomics Technology
Gurufocus Stories at Macroaxis
few days ago at finance.yahoo.com         
Illumina unveils first-of-its-kind spatial transcriptomics technology
Yahoo News
few days ago at gurufocus.com         
Illumina Inc Announces Webcast of Investor Session at AGBT Conference
Gurufocus Stories at Macroaxis
six days ago at thelincolnianonline.com         
Mcdonald Partners LLC Lowers Stake in Illumina, Inc.
news
over a week ago at kalkinemedia.com         
Life Science Tools Market Is Booming Worldwide 2025-2032 Hitachi, Ltd., Illumina, Inc., Oxford Instr...
news
over a week ago at talkmarkets.com         
Disposition of 2064 shares by Jacob Thaysen of Illumina at 101.09 subject to Rule 16b-3
news
over a week ago at kalkinemedia.com         
How Are Market Fluctuations Impacting Illumina
news
a minute ago at thelincolnianonline.com         
AbbVie Inc. Shares Sold by Janney Montgomery Scott LLC
news
a day ago at benzinga.com         
Heres How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
benzinga news
3 days ago at thelincolnianonline.com         
AbbVie Inc. Shares Sold by VisionPoint Advisory Group LLC
news
few days ago at thelincolnianonline.com         
Peoples Bank OH Lowers Position in AbbVie Inc.
news
few days ago at thelincolnianonline.com         
AbbVie Inc. Shares Purchased by Waterfront Wealth Inc.
news
few days ago at thelincolnianonline.com         
Corps Capital Advisors LLC Makes New 1.63 Million Investment in AbbVie Inc.
news
few days ago at finance.yahoo.com         
The Art of Valuation Discovering AbbVie Incs Intrinsic Value
Yahoo News
few days ago at thelincolnianonline.com         
AbbVie Inc. Enters into Underwriting Agreement for Senior Notes Issuance
news
six days ago at thelincolnianonline.com         
Kestra Investment Management LLC Buys 1,579 Shares of AbbVie Inc.
news
six days ago at finance.yahoo.com         
Acquisition by Robert Michael of 14454 shares of AbbVie subject to Rule 16b-3
Yahoo News
a minute ago at thelincolnianonline.com         
Gilead Sciences, Inc. CFO Andrew D. Dickinson Sells 142,180 Shares
news
2 days ago at insidermonkey.com         
Gilead Sciences, Inc. Among Renaissance Technologies Portfolios Top Stock Picks
insidermonkey News
3 days ago at techradar.com         
The Handmaids Tale season 6 everything we know so far about the hit Hulu shows return
news
few days ago at finance.yahoo.com         
Some Investors May Be Willing To Look Past Gilead Sciences Soft Earnings
Yahoo News
few days ago at businesswire.com         
Gileads Seladelpar Granted Conditional European Marketing Authorization for the Treatment of Primary...
businesswire News
few days ago at insidermonkey.com         
Gilead Sciences, Inc. Among Stocks That Analysts Think Will Go Up
insidermonkey News
few days ago at kalkinemedia.com         
The Centrifuge Sessions How Gilead Sciences Is Impacting Autoimmune Disease
news
few days ago at thelincolnianonline.com         
Gilead Sciences, Inc. Position Boosted by Principal Financial Group Inc.
news
six days ago at seekingalpha.com         
Arcus stock falls as Gilead opts out cancer drug
seekingalpha News
six days ago at finance.yahoo.com         
Gilead Sciences Full Year 2024 Earnings Beats Expectations
Yahoo News
few days ago at finance.yahoo.com         
Exact Sciences Full Year 2024 Earnings EPS Misses Expectations
Yahoo News
few days ago at gurufocus.com         
Exact Sciences Corp Shares Gap Down to 49.26 on Feb 21
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Why Exact Sciences Stock is Moving Today
Gurufocus Stories at Macroaxis
few days ago at businesswire.com         
Exact Sciences Announces Fourth Quarter 2024 Results
businesswire News
few days ago at benzinga.com         
Exact Sciences Stock Slides On Q4 Earnings The Details
benzinga news
over a week ago at thelincolnianonline.com         
Quantum Private Wealth LLC Sells 16,499 Shares of Exact Sciences Co.
news
over two weeks ago at finance.yahoo.com         
When Can We Expect A Profit From Exact Sciences Corporation?
Yahoo News
over two weeks ago at gurufocus.com         
Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members
Gurufocus Stories at Macroaxis
over two weeks ago at businesswire.com         
Exact Sciences Schedules Fourth Quarter 2024 Earnings Call
businesswire News
over three weeks ago at thelincolnianonline.com         
Slow Capital Inc. Purchases 5,346 Shares of Exact Sciences Co.
news
2 days ago at thelincolnianonline.com         
Transcend Capital Advisors LLC Grows Holdings in Corteva, Inc.
news
3 days ago at thelincolnianonline.com         
ING Groep NV Lowers Position in Corteva, Inc.
news
few days ago at thelincolnianonline.com         
Corteva Director Rebecca Liebert Resigns
news
few days ago at gurufocus.com         
Corteva Inc to Present at Bank of America Global Agriculture Materials Conference
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Corteva, Inc. Announces Board Member Resignation
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Disposition of 46905 shares by Charles Magro of Corteva at 63.82 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
six days ago at thelincolnianonline.com         
Acquisition by Charles Magro of 97859 shares of Corteva at 64.46 subject to Rule 16b-3
news
over a week ago at simplywall.st         
Has Corteva, Inc. Stocks Recent Performance Got Anything to Do With Its Financial Health?
Simply Wall St News at Macroaxis
over a week ago at prnewswire.com         
IBI Ag Secures 6.1 Million in Funding Round Led by Corteva Inc.
prnewswire News
over a week ago at kalkinemedia.com         
Agriculture Biotech Market is Set To Fly High in Years to Come ChemChina, Bayer AG, Corteva, Nufarm
news
a day ago at finance.yahoo.com         
BioMarin Announces Appointment of Timothy P. Walbert to Board of Directors
Yahoo News
few days ago at finance.yahoo.com         
BioMarin Pharmaceutical Full Year 2024 Earnings Beats Expectations
Yahoo News
few days ago at finance.yahoo.com         
Why BioMarin Pharmaceutical Stock Is Trading Up Today
Yahoo News
few days ago at finance.yahoo.com         
Why BioMarin Pharmaceutical Stock Zoomed Almost 5 percent Higher Today
Yahoo News
few days ago at seekingalpha.com         
BioMarin rises as 2025 EPS guidance range above consensus
seekingalpha News
few days ago at finance.yahoo.com         
Compared to Estimates, BioMarin Q4 Earnings A Look at Key Metrics
Yahoo News
six days ago at finance.yahoo.com         
Hemophilia Market Insights Key Trends and Developments Across Different Types of Hemophilia DelveIns...
Yahoo News
over a week ago at zacks.com         
Are You a Value Investor This 1 Stock Could Be the Perfect Pick
zacks News
over a week ago at zacks.com         
Ultragenyx Q4 Loss Wider Than Expected, Revenues Increase YY
zacks News
over a week ago at zacks.com         
Unveiling BioMarin Q4 Outlook Wall Street Estimates for Key Metrics
zacks News
a minute ago at kalkinemedia.com         
Japan gives priority review status to Alzheimers drug developed by Eisai, Biogen
news
2 days ago at thelincolnianonline.com         
Biogen Inc. Stock Position Increased by Callan Capital LLC
news
few days ago at finance.yahoo.com         
Ionis Q4 Earnings and Sales Beat Estimates, Tryngolza Launch in Focus
Yahoo News
few days ago at marketbeat.com         
Biogen Stock Is Mutating Into a Value Play
Marketbeat News
few days ago at finance.yahoo.com         
Biogen and Stoke Therapeutics to commercialise Dravet syndrome treatment
Yahoo News
few days ago at businesswire.com         
Ionis reports fourth quarter and full year 2024 financial results
businesswire News
six days ago at bizjournals.com         
Biogen continues dealmaking buzz with Stoke Therapeutics
bizjournals News
six days ago at kalkinemedia.com         
How Are Financial Firms Modifying Their Stakes in Biogen Inc.
news
over a week ago at thelincolnianonline.com         
Strategic Financial Concepts LLC Invests 2.99 Million in Biogen Inc.
news
over a week ago at thelincolnianonline.com         
Acquisition by Robin Kramer of 351 shares of Biogen subject to Rule 16b-3
news
a minute ago at businesswire.com         
AstraZenecas Full Year and Q4 2024 results
businesswire News
2 days ago at thelincolnianonline.com         
Amgen Inc. Shares Bought by Hudson Value Partners LLC
news
3 days ago at thelincolnianonline.com         
Amgen Inc. Shares Acquired by Callan Capital LLC
news
few days ago at thelincolnianonline.com         
Lakeside Advisors INC. Increases Stock Holdings in Amgen Inc.
news
few days ago at cnbc.com         
From pills to new uses, heres what Eli Lillys top scientist sees as the future of weight loss drugs
cnbc News
few days ago at businesswire.com         
Verastem Oncology Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annu...
businesswire News
few days ago at finance.yahoo.com         
Disposition of 1524 shares by Derek Miller of Amgen at 156.35 subject to Rule 16b-3
Yahoo News
six days ago at finance.yahoo.com         
Perceive Pharma Attracts 15M Series A Financing to Advance Ophthalmic Neuroprotection
Yahoo News
six days ago at thelincolnianonline.com         
Bfsg LLC Purchases 9 Shares of Amgen Inc.
news
over a week ago at finance.yahoo.com         
JJ Stock Up More Than 6 percent in a Month Time to Buy, Sell or Hold?
Yahoo News
Far too much social signal, news, headlines, and media speculation about Biotechnology Fund that are available to investors today. That information is available publicly through Biotechnology media outlets and privately through word of mouth or via Biotechnology internal channels. However, regardless of the origin, that massive amount of Biotechnology data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biotechnology Fund news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biotechnology Fund relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biotechnology Fund's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biotechnology Fund alpha.

Other Information on Investing in Biotechnology Mutual Fund

Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Fundamental Analysis
View fundamental data based on most recent published financial statements
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
News Freq…Investor S…